If you purchased or acquired securities in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TransMedics Group, ...
The Allegations: Robbins LLP is Investigating Allegations that TransMedics Group, Inc. (TMDX) Misled Investors Regarding its Coercive and Unsafe Business Practices According to the complaint ...
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMD ...
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts ...
CASE ALLEGATIONS: TransMedics is a commercial-stage medical technology company that engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and ...